Correlation Between Lixte Biotechnology and Burzynski Research

Can any of the company-specific risk be diversified away by investing in both Lixte Biotechnology and Burzynski Research at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lixte Biotechnology and Burzynski Research into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lixte Biotechnology Holdings and Burzynski Research, you can compare the effects of market volatilities on Lixte Biotechnology and Burzynski Research and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lixte Biotechnology with a short position of Burzynski Research. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lixte Biotechnology and Burzynski Research.

Diversification Opportunities for Lixte Biotechnology and Burzynski Research

-0.14

Correlation Coefficient

Lixte Biotechnology  Burzynski Research

Good diversification

The 3 months correlation between Lixte and Burzynski is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Lixte Biotechnology Holdings and Burzynski Research in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Burzynski Research and Lixte Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lixte Biotechnology Holdings are associated (or correlated) with Burzynski Research. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Burzynski Research has no effect on the direction of Lixte Biotechnology i.e., Lixte Biotechnology and Burzynski Research go up and down completely randomly.

Pair Corralation between Lixte Biotechnology and Burzynski Research

Given the investment horizon of 90 days Lixte Biotechnology Holdings is expected to under-perform the Burzynski Research. But the stock apears to be less risky and, when comparing its historical volatility, Lixte Biotechnology Holdings is 2.65 times less risky than Burzynski Research. The stock trades about -0.08 of its potential returns per unit of risk. The Burzynski Research is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  5.00  in Burzynski Research on December 29, 2024 and sell it today you would lose (2.00) from holding Burzynski Research or give up 40.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.39%
Values	Daily Returns

Lixte Biotechnology Holdings  vs.  Burzynski Research

Lixte Biotechnology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lixte Biotechnology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Burzynski Research

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Burzynski Research are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Burzynski Research reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Lixte Biotechnology and Burzynski Research

The main advantage of trading using opposite Lixte Biotechnology and Burzynski Research positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lixte Biotechnology position performs unexpectedly, Burzynski Research can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Burzynski Research will offset losses from the drop in Burzynski Research's long position.

The idea behind Lixte Biotechnology Holdings and Burzynski Research pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.